Editors' Series: The Importance of In-House Testing for Cannabis and Hemp Businesses
Cannabis is medicine and it should be tested like medicine. This means the cannabis industry needs to adopt the pharmaceutical industry testing paradigm of cradle to grave testing. This webcast will discuss the technologies available for in-house testing, and how it can increase profitability and reduce compliance failures. Live: Wednesday, Nov. 20, 2019 at 11am EST | 8am PST | 4pm GMT | 5pm CETOn demand available after airing until Nov. 20, 2020.
Register Free:http://www.cannabissciencetech.com/cst_w/importance
Event Overview:
Cannabis is medicine and it should be tested like medicine. This means the cannabis industry needs to adopt the pharmaceutical industry testing paradigm of cradle to grave testing. Our industry needs to test raw materials, after each manufacturing step, and the final product to insure the safety and efficacy of the medicines we manufacture. Sending samples out to third party labs is not practical because the results take too long, which is why cannabis businesses need to do their own testing. The technologies available for this as well as how in-house testing can increase profitability and reduce compliance failures will be discussed.
Key Learning Objectives:
- Technology available for in-house testing
- How can in-house testing increase profitability in the cannabis industry
- How can in-house testing reduce compliance failures in cannabis
- Cradle to grave cannabis testing
Time and date: Wednesday, Nov. 20, 2019 at 11am EST | 8am PST | 4pm GMT | 5pm CET
On demand available after airing until Nov. 20, 2020.
Sponsor: Sartorius
Register Free:http://www.cannabissciencetech.com/cst_w/importance
Getting Started with GC Analysis for Cannabis
January 31st 2018Want to begin cannabis testing but don’t know where to start? Register now to find out how even somebody with no previous GC experience can start in house testing of cannabis samples. On Demand webcast available until Jan. 31, 2019.
